Cincinnati Eye Institute

Edgewood, Kentucky 41017

0 studies enrolling now · 24 studies all time

What they study most

Bacterial Conjunctivitis, Cataract, Cataracts, Corneal Blindness, Corneal Disease, Corneal Edema, Corneal Injuries, Corneal Opacity, Dry Eye, Dry Eye Disease, Dry Eye Syndromes, Fuchs' Corneal Endothelial Dystrophy (FCED)

Studies at this site

• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects — Completed
• DEFENDO Long Term Follow-up Study in Stage 1 NK Patients — Completed
• Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA) — Completed
• TearCare System to Treat Dry Eye Disease — Completed
• Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease — Stopped early
• Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease — Completed
• A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease — Completed
• First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness — Stopped early
• Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit — Completed
• ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects — Stopped early
• A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy — Completed
• Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca — Completed
• A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia — Completed
• A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED) — Completed
• ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects — Completed
• Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo — Completed
• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease — Completed
• A Clinical Study to Evaluate the KeraKlear Keratoprosthesis in Patients With Corneal Opacity — Stopped early
• Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery — Completed
• A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery — Completed
• Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5% — Completed
• A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma — Completed
• A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® — Withdrawn before enrolling
• Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. — Completed